Your browser doesn't support javascript.
loading
Outcome of rare primary malignant bone sarcoma treated with multimodal therapy: Results from the EUROpean Bone Over 40 Sarcoma Study (EURO-B.O.S.S.).
Palmerini, Emanuela; Reichardt, Peter; Hall, Kirsten Sundby; Bertulli, Rossella; Bielack, Stefan S; Comandone, Alessandro; Egerer, Gerlinde; Hansmeier, Anna; Kevric, Matthias; Carretta, Elisa; Hansson, Lina; Jebsen, Nina; Eriksson, Mikael; Bruland, Øyvind S; Donati, Davide Maria; Ibrahim, Toni; Smeland, Sigbjørn; Ferrari, Stefano.
Afiliação
  • Palmerini E; Osteoncology, Bone and Soft Tissue Sarcomas, and Innovative Therapies, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.
  • Reichardt P; Sarcoma Center, Helios Klinikum Berlin-Buch, Berlin, Germany.
  • Hall KS; Department of Oncology, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.
  • Bertulli R; Adult Mesenchymal Tumor Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
  • Bielack SS; Cooperative Osteosarcoma Study Group, Klinikum Stuttgart-Olgahospital, Stuttgart, Germany.
  • Comandone A; SC Oncologia Azienda Sanitaria Locale "Città di Torino" Ospedale San Giovanni Bosco Torino, Turin, Italy.
  • Egerer G; University Hospital Heidelberg, Heidelberg, Germany.
  • Hansmeier A; Department of Hematology and Oncology, University Hospital Münster, Munster, Germany.
  • Kevric M; Cooperative Osteosarcoma Study Group, Klinikum Stuttgart-Olgahospital, Stuttgart, Germany.
  • Carretta E; Department of Programming and Monitoring, IRCCS Istituto Ortopedico RizzolI, Bologna, Italy.
  • Hansson L; Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Jebsen N; Haukeland University Hospital, Bergen, Norway.
  • Eriksson M; Skåne University Hospital, Lund, Sweden.
  • Bruland ØS; Department of Oncology, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.
  • Donati DM; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Ibrahim T; Orthopedic Oncology, IRCCS Istituto Ortopedico RizzolI, Bologna, Italy.
  • Smeland S; Osteoncology, Bone and Soft Tissue Sarcomas, and Innovative Therapies, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.
  • Ferrari S; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Cancer ; 129(22): 3564-3573, 2023 11 15.
Article em En | MEDLINE | ID: mdl-37530385
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sarcoma / Neoplasias Ósseas / Osteossarcoma / Leiomiossarcoma Tipo de estudo: Guideline / Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sarcoma / Neoplasias Ósseas / Osteossarcoma / Leiomiossarcoma Tipo de estudo: Guideline / Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2023 Tipo de documento: Article